| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $20.7M | +21.0% |
| SG&A Expense | $74.5M | +8.8% |
| Operating Income | -$98.6M | -15.2% |
| Interest Expense | $12.3M | +24.1% |
| Pre-tax Income | -$111.4M | -19.6% |
| Income Tax | $26.0M | +264.5% |
| Net Income | -$137.5M | -77.8% |
| EPS (Basic) | -$2.29 | -73.5% |
| EPS (Diluted) | -$2.29 | -73.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.0M | +45.9% |
| Short-term Investments | $22.5M | — |
| Current Assets | $100.8M | -47.6% |
| Total Assets | $132.8M | -46.3% |
| Current Liabilities | $55.8M | +165.7% |
| Long-term Debt | $91.6M | -35.7% |
| Total Liabilities | $153.9M | -8.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.3M | +9.1% |
| Capital Expenditures | $716K | +2653.8% |
| Investing Cash Flow | $79.7M | +40.0% |
| Financing Cash Flow | $14.5M | +5429.7% |
| Free Cash Flow | -$71.0M | +8.2% |
| Stockholders' Equity |
| -$21.1M |
| -127.0% |